Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Secondary Spinal Cord Injury llI: Pathophysiology

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

Journal of neurology, neurosurgery, and psychiatry·2026

Same author

Spinal cord reserve is associated with multi-dimensional clinical resilience in multiple sclerosis.

Journal of neurology·2026

Same author

Redefining Multiple Sclerosis: Toward a Biologically Driven Diagnosis.

Neurology·2026

Same author

Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis.

Brain : a journal of neurology·2026

Same author

An automated quantitative report for multiple sclerosis using only 3D T2-fluid-attenuated inversion recovery MRI.

Neuroradiology·2026

Same author

Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity.

JAMA network open·2026

Same journal

Ataxia Global Initiative recommend MRI end-points for clinical trials in ataxias.

Nature reviews. Neurology·2026

Same journal

Adaptive deep brain stimulation in Parkinson disease: clinical implementation and outlook.

Nature reviews. Neurology·2026

Same journal

Moving artificial intelligence from research to real-world clinical use in neurology.

Nature reviews. Neurology·2026

Same journal

Artificial intelligence in headache care.

Nature reviews. Neurology·2026

Same journal

Artificial intelligence could reshape research and care in disorders of consciousness.

Nature reviews. Neurology·2026

Same journal

Christina Kim: functional and biochemical mapping of neural circuits.

Nature reviews. Neurology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Multiple sclerosis: Lesion location may predict disability in multiple sclerosis.

Jaume Sastre-Garriga¹, Mar Tintoré

¹Centre d'Esclerosi Múltiple de Catalunya, Hospital Universitari Vall d'Hebron, Passeig de la Vall d'Hebron 119-129, Barcelona, Spain.

Nature Reviews. Neurology

|December 7, 2010

Summary

This summary is machine-generated.

Lesion location in primary progressive multiple sclerosis (MS) is key for predicting long-term disability. Specific brain regions with MS lesions indicate an early need for walking support.

More Related Videos

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Related Experiment Videos

Last Updated: Jun 6, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Area of Science:

Neuroscience
Neurology
Medical Imaging

Background:

Primary progressive multiple sclerosis (MS) is a debilitating neurological disease.
Predicting long-term disability in MS patients is crucial for timely intervention.
Lesion location and burden are known factors influencing MS progression.

Discussion:

This study utilizes lesion probability mapping to analyze the spatial distribution of MS lesions.
The research identifies specific brain regions where lesion presence correlates with functional decline.
Findings suggest that lesion location is a significant predictor of disability progression in primary progressive MS.

Key Insights:

MS lesion location in specific brain areas predicts an early need for bilateral walking support.
Lesion probability mapping offers a novel approach to understanding MS-related disability.
Early identification of patients at risk for mobility impairment can guide therapeutic strategies.

Outlook:

Further research should validate these findings in larger, diverse MS cohorts.
Integrating lesion location data into clinical assessments could improve prognostic accuracy.
This approach may pave the way for personalized treatment plans in progressive MS.